Novartis AG
Antiviral Pyrazolopyridinone Compounds

Last updated:

Abstract:

The invention provides compounds of Formula (I) ##STR00001## as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.

Status:
Application
Type:

Utility

Filling date:

24 Sep 2020

Issue date:

6 May 2021